To study the short and long term differences in outcome between patients > or =80 years of age and those < or =79 years of age who received intravenous recombinant tissue plasminogen activator (iv rt-PA) for acute stroke within the first 3 hours of symptom onset.
Department of Medicine, Division of Neurology, University of Alberta, 2E3.13 Walter C Mackenzie Health Sciences Centre, Edmonton, Alberta, Canada T6G 2B7.
